Docket Number:12A-1070927
Inventor:Patrick Ching-Ho Hsieh, Tony W.H. Tang, Hung-Chih Chen
IP Status:USP
Abstract:
The imbalanced microbiome affects the host immune system and impairs its function in cardiac repair after myocardial infarction. This increases myocardial infarction mortality. According to this invention, fecal reconstitution, transplantation of monocytes, dietary short-chain fatty acid or Lactobacillus probiotic supplementation is able to enhance the post-infarction myocardial repair.
Fields of Application:
Enhance the function of cardiac repair after myocardial infarction.
Advantages when compared to the existing technologies:
The study uncovers the adverse effects of antibiotics on survival after myocardial infarction and addresses the combinatorial supplementation of short chain fatty acids or probiotics before MI and transplantation of monocytes after MI is a novel therapeutic approach.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
